197 related articles for article (PubMed ID: 36282941)
1. Surface Presentation of Hyaluronic Acid Modulates Nanoparticle-Cell Association.
Deiss-Yehiely E; Brucks SD; Boehnke N; Pickering AJ; Kiessling LL; Hammond PT
Bioconjug Chem; 2022 Nov; 33(11):2065-2075. PubMed ID: 36282941
[TBL] [Abstract][Full Text] [Related]
2. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T
Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019
[TBL] [Abstract][Full Text] [Related]
3. Bimodal tumor-targeting from microenvironment responsive hyaluronan layer-by-layer (LbL) nanoparticles.
Dreaden EC; Morton SW; Shopsowitz KE; Choi JH; Deng ZJ; Cho NJ; Hammond PT
ACS Nano; 2014 Aug; 8(8):8374-82. PubMed ID: 25100313
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting.
Song S; Qi H; Xu J; Guo P; Chen F; Li F; Yang X; Sheng N; Wu Y; Pan W
Pharm Res; 2014 Nov; 31(11):2988-3005. PubMed ID: 24842660
[TBL] [Abstract][Full Text] [Related]
5. Development of drug loaded nanoparticles for tumor targeting. Part 1: Synthesis, characterization, and biological evaluation in 2D cell cultures.
El-Dakdouki MH; Puré E; Huang X
Nanoscale; 2013 May; 5(9):3895-903. PubMed ID: 23529646
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous arrangement of a tumor targeting hyaluronic acid shell on irinotecan loaded PLGA nanoparticles.
Giarra S; Serri C; Russo L; Zeppetelli S; De Rosa G; Borzacchiello A; Biondi M; Ambrosio L; Mayol L
Carbohydr Polym; 2016 Apr; 140():400-7. PubMed ID: 26876867
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells.
Sargazi A; Shiri F; Keikha S; Majd MH
Colloids Surf B Biointerfaces; 2018 Nov; 171():150-158. PubMed ID: 30025377
[TBL] [Abstract][Full Text] [Related]
8. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
[TBL] [Abstract][Full Text] [Related]
9. Layer-by-layer pH-sensitive nanoparticles for drug delivery and controlled release with improved therapeutic efficacy
Men W; Zhu P; Dong S; Liu W; Zhou K; Bai Y; Liu X; Gong S; Zhang S
Drug Deliv; 2020 Dec; 27(1):180-190. PubMed ID: 31924103
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronan-Metal Gold Nanoparticle Hybrids for Targeted Tumor Cell Therapy.
Sanfilippo V; Caruso VCL; Cucci LM; Inturri R; Vaccaro S; Satriano C
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349323
[TBL] [Abstract][Full Text] [Related]
11. Near infrared fluorescent nanoparticles based on hyaluronic acid: Self-assembly, optical properties, and cell interaction.
Kelkar SS; Hill TK; Marini FC; Mohs AM
Acta Biomater; 2016 May; 36():112-21. PubMed ID: 26995504
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid-serum albumin conjugate-based nanoparticles for targeted cancer therapy.
Edelman R; Assaraf YG; Levitzky I; Shahar T; Livney YD
Oncotarget; 2017 Apr; 8(15):24337-24353. PubMed ID: 28212584
[TBL] [Abstract][Full Text] [Related]
13. Stiffness of targeted layer-by-layer nanoparticles impacts elimination half-life, tumor accumulation, and tumor penetration.
Kong SM; Costa DF; Jagielska A; Van Vliet KJ; Hammond PT
Proc Natl Acad Sci U S A; 2021 Oct; 118(42):. PubMed ID: 34649991
[TBL] [Abstract][Full Text] [Related]
14. CD44-Targeted Hyaluronic Acid-Coated Redox-Responsive Hyperbranched Poly(amido amine)/Plasmid DNA Ternary Nanoassemblies for Efficient Gene Delivery.
Gu J; Chen X; Ren X; Zhang X; Fang X; Sha X
Bioconjug Chem; 2016 Jul; 27(7):1723-36. PubMed ID: 27311558
[TBL] [Abstract][Full Text] [Related]
15. Mannosylation Allows for Synergic (CD44/C-Type Lectin) Uptake of Hyaluronic Acid Nanoparticles in Dendritic Cells, but Only upon Correct Ligand Presentation.
Gennari A; Pelliccia M; Donno R; Kimber I; Tirelli N
Adv Healthc Mater; 2016 Apr; 5(8):966-76. PubMed ID: 26865006
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes.
Qhattal HS; Hye T; Alali A; Liu X
ACS Nano; 2014 Jun; 8(6):5423-40. PubMed ID: 24806526
[TBL] [Abstract][Full Text] [Related]
17. One-pot preparation of hyaluronic acid-coated iron oxide nanoparticles for magnetic hyperthermia therapy and targeting CD44-overexpressing cancer cells.
Soleymani M; Velashjerdi M; Shaterabadi Z; Barati A
Carbohydr Polym; 2020 Jun; 237():116130. PubMed ID: 32241421
[TBL] [Abstract][Full Text] [Related]
18. CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
Byeon Y; Lee JW; Choi WS; Won JE; Kim GH; Kim MG; Wi TI; Lee JM; Kang TH; Jung ID; Cho YJ; Ahn HJ; Shin BC; Lee YJ; Sood AK; Han HD; Park YM
Cancer Res; 2018 Nov; 78(21):6247-6256. PubMed ID: 30115698
[TBL] [Abstract][Full Text] [Related]
19. Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes.
Qhattal HS; Liu X
Mol Pharm; 2011 Aug; 8(4):1233-46. PubMed ID: 21696190
[TBL] [Abstract][Full Text] [Related]
20. Cellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugates.
Cai S; Alhowyan AA; Yang Q; Forrest WC; Shnayder Y; Forrest ML
J Drug Target; 2014 Aug; 22(7):648-57. PubMed ID: 24892741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
